Initial Workup and Management
Check serum TSH and free T4 immediately to assess for levothyroxine overtreatment, which can cause cardiovascular symptoms including syncope, dizziness, and atrial arrhythmias—particularly concerning given her morning-predominant symptoms and recent stress. 1
Immediate Diagnostic Priorities
Thyroid Function Assessment
The combination of syncope, dizziness, and tinnitus in a patient on levothyroxine 112 mcg raises concern for thyroid hormone excess causing cardiovascular instability. Overtreatment occurs in 20% of patients on thyroid hormone and can manifest with:
- Atrial arrhythmias (especially atrial fibrillation)
- Cardiovascular symptoms including syncope
- Anxiety and stress intolerance 1
Order immediately:
- Serum TSH (target: 0.27-4.2 mIU/L)
- Free T4
- Complete metabolic panel
- Complete blood count
Cardiovascular Evaluation
Given the syncope episode, obtain:
- 12-lead ECG to assess for arrhythmias, bradycardia, or conduction abnormalities
- Orthostatic vital signs (hypothyroidism can cause bradycardia and syncope; hyperthyroidism can cause tachyarrhythmias) 2
- Consider Holter monitoring if ECG is non-diagnostic
Medication Compliance and Absorption Assessment
Critical questions to ask:
- Is she taking levothyroxine on an empty stomach, 30-60 minutes before breakfast?
- Any new medications, particularly iron, calcium, proton pump inhibitors, or antacids? 3, 4
- Any gastrointestinal symptoms suggesting malabsorption?
- Compliance pattern—any missed or doubled doses?
The morning-predominant dizziness could indicate she's taking levothyroxine with food or other medications, reducing absorption 3.
Differential Diagnosis Framework
If TSH is Suppressed (<0.1 mIU/L) with Elevated Free T4:
Levothyroxine overtreatment is confirmed. This explains:
- Cardiovascular symptoms (syncope, palpitations)
- Anxiety exacerbation
- Morning symptoms (peak drug effect)
Management:
- Reduce levothyroxine dose by 12.5-25 mcg 1
- Recheck TSH in 6-8 weeks 3
- Consider cardiology referral if arrhythmia detected
If TSH is Elevated (>4.5 mIU/L) with Low Free T4:
Undertreatment or absorption issue. Investigate:
- Medication interactions (especially iron, calcium, PPIs) 4
- Compliance issues (most common cause) 1
- Malabsorption syndromes
- Consider supervised levothyroxine absorption test if absorption suspected 4
Hypothyroidism can cause bradycardia and syncope, though less common 2.
If TSH is Normal (0.27-4.2 mIU/L):
Look beyond thyroid:
- Vestibular causes (unilateral tinnitus + dizziness suggests Ménière's disease or vestibular neuritis)
- Cardiac arrhythmias independent of thyroid status
- Anxiety/panic disorder (though don't attribute everything to stress without excluding organic causes)
- Orthostatic hypotension
Specific Management Algorithm
Week 1:
- Obtain labs (TSH, free T4, CBC, CMP) and ECG
- Review medication timing and interactions
- Assess orthostatic vitals
- If syncope recurs or cardiac symptoms worsen → emergency department evaluation
Week 2-3 (based on results):
- If overtreatment confirmed: Reduce dose, counsel on cardiac monitoring
- If undertreatment confirmed: Investigate absorption, adjust dose, separate from interfering medications by 4+ hours 3
- If thyroid function normal: Refer to ENT for audiometry and vestibular testing (unilateral tinnitus warrants evaluation)
Week 6-8:
- Recheck TSH after any dose adjustment 3
- Reassess symptoms
Critical Pitfalls to Avoid
Don't dismiss cardiovascular symptoms as "just anxiety" in a patient on levothyroxine—overtreatment causes real cardiac morbidity including atrial fibrillation and increased cardiovascular mortality 1
Don't assume adequate dosing based on prescription alone—absorption issues are common, especially with concurrent iron supplementation (even with 4-hour separation) 4
Don't overlook the unilateral tinnitus—this is NOT a typical thyroid symptom and warrants ENT evaluation for acoustic neuroma, Ménière's disease, or other vestibular pathology
Don't adjust levothyroxine based on symptoms alone—TSH is the most reliable therapeutic endpoint 1
Morning-predominant symptoms suggest peak drug effect timing—if overtreatment confirmed, this pattern supports the diagnosis
The stress and anxiety may be secondary to thyroid dysfunction (either direction) rather than the primary cause, so biochemical confirmation is essential before attributing symptoms to psychological factors alone.